Section 3(d) and the Evergreening Debate in Indian Pharma Patents
Few provisions in the entire canon of global intellectual property law have attracted as much sustained attention, controversy and scholarly debate as Section 3(d) of the Patents Act, 1970. In the two decades since India inserted this provision into its patent statute as part of the 2005 amendment that brought the country into compliance with […]
Section 3(d) and the Evergreening Debate in Indian Pharma Patents Read More »









